Table 3.

Clinician and patient-reported measures retained in final multivariate models for 6-month treatment response

CharacteristicTotal (N = 347)Training (n = 183)Validation (n = 164)P value 
Clinician-reported measures     
PROM at baseline 21.7 (12.0-25.0) 21.6 (13.0-25.0) 21.9 (12.0-25.0) .44 
285 136 149  
PROM change 0.3 (−12.0 to 8.0) 0.2 (−12.0 to 8.0) 0.3 (−11.0 to 7.0) .79 
265 129 136  
NIH skin score change −0.2 (−3.0 to 3.0) −0.3 (−3.0 to 2.0) −0.2 (−3.0 to 3.0) .56 
340 180 160  
Patient-reported measures     
Modified HAP at baseline 64.5 (9.0-94.0) 64.9 (9.0-94.0) 64.0 (24.0-94.0) .63 
299 161 138  
SF36 vitality change 1.1 (−21.9 to 31.2) 1.5 (−21.9 to 31.2) 0.7 (−21.9 to 25.0) .48 
 265 140 125  
LSS skin score at baseline 34.1 (0.0-100.0) 36.7 (0.0-100.0) 30.9 (0.0-100.0) .03 
303 165 138  
LSS skin score change −9.1 (−75.0 to 60.0) −9.4 (−75.0 to 35.0) −8.6 (−70.0 to 60.0) .76 
263 141 122  
CharacteristicTotal (N = 347)Training (n = 183)Validation (n = 164)P value 
Clinician-reported measures     
PROM at baseline 21.7 (12.0-25.0) 21.6 (13.0-25.0) 21.9 (12.0-25.0) .44 
285 136 149  
PROM change 0.3 (−12.0 to 8.0) 0.2 (−12.0 to 8.0) 0.3 (−11.0 to 7.0) .79 
265 129 136  
NIH skin score change −0.2 (−3.0 to 3.0) −0.3 (−3.0 to 2.0) −0.2 (−3.0 to 3.0) .56 
340 180 160  
Patient-reported measures     
Modified HAP at baseline 64.5 (9.0-94.0) 64.9 (9.0-94.0) 64.0 (24.0-94.0) .63 
299 161 138  
SF36 vitality change 1.1 (−21.9 to 31.2) 1.5 (−21.9 to 31.2) 0.7 (−21.9 to 25.0) .48 
 265 140 125  
LSS skin score at baseline 34.1 (0.0-100.0) 36.7 (0.0-100.0) 30.9 (0.0-100.0) .03 
303 165 138  
LSS skin score change −9.1 (−75.0 to 60.0) −9.4 (−75.0 to 35.0) −8.6 (−70.0 to 60.0) .76 
263 141 122  

Based on the t test.

Close Modal

or Create an Account

Close Modal
Close Modal